This study is currently not recruiting participants.

Comparison of Medication Assisted Treatment for Opioid Use Disorder in Male and Female Veterans

Investigating Gender Differences in Medication Assisted Treatment for Opioid Use Disorder (MAT)

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

While it is known that both men and women use opioids and are at risk of opioid use disorder (OUD), there is little data that investigates the gender differences with medication assisted treatment (MAT) therapies. Data is lacking regarding gender differences in baseline characteristics and diagnoses prior to MAT, and outcomes following MAT initiation. Women and men may have different factors leading to opioid use disorder, as well as varying MAT management. It is hypothesized that there is a gender disparity between men and women who are referred to SUDRP, and in the MAT therapies prescribed and the associated outcomes. The objectives are to assess gender differences in referrals to SUDRP, medications prescribed for MAT, and outcomes of OUD.

Detailed description of study

While it is known that both men and women use opioids and are at risk of opioid use disorder (OUD), there is little data that investigates the gender differences with medication assisted treatment (MAT) therapies. Data is lacking regarding gender differences in baseline characteristics and diagnoses prior to MAT, and outcomes following MAT initiation. Women and men may have different factors leading to opioid use disorder, as well as varying MAT management. It is hypothesized that there is a gender disparity between men and women who are referred to SUDRP, and in the MAT therapies prescribed and the associated outcomes. The objectives are to assess gender differences in referrals to SUDRP, medications prescribed for MAT, and outcomes of OUD.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Opioid Use Disorder
  • Age: 100 years or below
  • Gender: All

This study investigates how gender differences affect the treatment of opioid use disorder (OUD) with medication assisted treatment (MAT). Opioid use disorder is a condition where a person has a problematic pattern of opioid use that causes significant impairment or distress. The study aims to understand if there are differences between men and women in terms of their initial characteristics and diagnoses before starting MAT, as well as the outcomes after starting the treatment.

Participants in the study will undergo assessments to determine the differences in how men and women are referred to substance use disorder rehabilitation programs (SUDRP), the types of medications prescribed for MAT, and the outcomes of these treatments. This involves collecting data on baseline characteristics and tracking the progress and results of the treatment to identify any gender-specific trends.

  • Who can participate: The study is open to adults aged 18 and over who have been diagnosed with opioid use disorder and are eligible for medication assisted treatment. Participants must be referred to a substance use disorder rehabilitation program.
  • Study details: Participants will be assessed on their referral to substance use disorder rehabilitation programs and the medication prescribed for their treatment. The study will compare outcomes based on gender differences. An inactive substance that looks like the investigational medicine but does not contain any medicine will not be used in this study.
Updated on 19 Feb 2024. Study ID: 1809354103

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team